Dust mite allergy shot therapy for kids with rhinitis or asthma
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 5 and 18 years old.
- Your child has allergic rhinitis or asthma caused by dust mites, shown by a positive skin test or a blood test (IgE level at least 0.70 kU/L).
- Your child has had a special blood test that identifies exactly which dust mite proteins they are allergic to.
- If your child has asthma, it must be well-controlled based on standard asthma guidelines.
- Your child is already getting dual-mite allergy shots (subcutaneous immunotherapy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a procedure that shrinks the tissue inside your nose (called radiofrequency ablation) plus allergy shots (immunotherapy) helps reduce severe nasal blockage caused by dust mite allergy. It aims to improve breathing and reduce allergy symptoms.
This study looks at how safe and well-tolerated a specific allergy immunotherapy treatment for house dust mite allergies is when the dose is increased in one step. If you are already planning to start this treatment, this study helps track how it works in real life.
This study looks at how sublingual immunotherapy tablets, which are placed under the tongue, affect the body's response to dust mite allergies in people with allergic rhinitis. The goal is to understand how these tablets might change the immune system and help improve symptoms.
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
This trial tests a new allergy shot that may reduce symptoms of dust mite allergies, like sneezing, runny nose, and itchy eyes. It might also help with mild asthma caused by dust mites.
This trial tests if allergy shots (allergen-specific immunotherapy) can reduce symptoms of moderate to severe dust mite allergy. You will be in a room that exposes you to dust mites to see how well the treatment works, compared to a placebo.
Hear when a new Allergic Rhinitis Due to House Dust Mite trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.